Status:
WITHDRAWN
The Natural History of Procalcitonin in Hemorrhagic Stroke
Lead Sponsor:
CAMC Health System
Conditions:
Intraventricular Hemorrhage
Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
Approximately 12% of strokes in the United States are hemorrhagic.1 Hemorrhagic stroke can lead to multiple complications including fever that is not infectious. Identifying the cause of fever can hel...
Detailed Description
Stroke is the second leading killer worldwide and the third leading cause of death in the United States. The two major mechanisms causing brain damage in stroke are, ischemia and hemorrhage. Several c...
Eligibility Criteria
Inclusion
- Hospitalization for an admitting diagnosis of hemorrhagic stroke admitted to the neurosurgical intensive care unit
- Age greater than 18 years
- No evidence of ischemic cerebrovascular injury
Exclusion
- Concomitant traumatic brain injury
- Antibiotics on admission to the NICU
- Immunocompromised by chemotherapy or HIV positive or patient with neutropenia (ANC \<1000)
- Women who are pregnant and/or of childbearing age where a pregnancy test has not already occurred
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01498705
Start Date
December 1 2011
End Date
December 1 2012
Last Update
February 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charleston Area Medical Center
Charleston, West Virginia, United States, 25301